HUM

HUM

USD

Humana Inc. Common Stock

$231.800+1.210 (0.525%)

Reaalajas hind

Healthcare
Healthcare Plans
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$230.590

Kõrge

$232.085

Madal

$227.760

Maht

1.51M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

28.0B

Tööstusharu

Healthcare Plans

Riik

United States

Kauplemisstatistika

Keskmine maht

1.76M

Börs

NYQ

Valuuta

USD

52 nädala vahemik

Madal $212.45Praegune $231.800Kõrge $406.46

Seotud uudised

BusinessWire

Humana Recognizes 10 Inspiring Athletes Who Are Redefining What It Means to Age

Presenting sponsor of the National Senior Games announces the Humana Game Changer Class of 2025 As the presenting sponsor of the 2025 National Senior Games, leading health and well-being company Humana Inc. (NYSE:HUM)

Vaata rohkem
Humana Recognizes 10 Inspiring Athletes Who Are Redefining What It Means to Age
Analyst Upgrades

Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $268

Barclays analyst Andrew Mok maintains Humana with a Equal-Weight and lowers the price target from $273 to $268.

Vaata rohkem
Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $268
PR Newswire

New PPO Dental Plans More Competitive Against HMOs

DentalInsurance.com, the leader in dental insurance comparison shopping, has broadened its inventory of PPO dental plans offering high maximum...

Vaata rohkem
New PPO Dental Plans More Competitive Against HMOs
PR Newswire

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces the Investigation of Humana Inc. (NASDAQ: HUM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Humana Inc. ("Humana") (NASDAQ: HUM), resulting...

Vaata rohkem
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces the Investigation of Humana Inc. (NASDAQ: HUM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
Reuters

Wall Street's potential winners and losers from Trump's tax bill

As President Donald Trump's sweeping tax-cut and spending bill heads to the Senate, analysts examine how his broad-ranging policies could turn the fortunes of U.S. companies if the package is enacted as law.

Vaata rohkem
Wall Street's potential winners and losers from Trump's tax bill
Reuters

Humana to back curbs to Medicare Advantage billing practices, WSJ reports

Humana has told congressional staffers that it will support moves that would curtail billing practices worth billions in extra payments to the industry, the Wall Street Journal reported, citing staffers and a document viewed by it.

Analyst Upgrades

Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $273

Barclays analyst Andrew Mok maintains Humana with a Equal-Weight and lowers the price target from $322 to $273.

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.